Automated tumor segmentation is emerging in treatment response assessment, though highly trained segmentation models are still met with limitations in fully automated response assessment due to nuances such as post-surgical enhancement and comparing location and morphology changes between timepoints.
Kamel et al. (Sat,) studied this question.